Home > Annual Financials > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES Financial Statement Analysis
[BOM: 509079|NSE : GUFICBIO]

The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]

ConsolidatedMar2025
Mar2024
Revenues ₹807 Cr₹807 Cr
Expenses ₹659 Cr₹659 Cr
Operating Profit (Excl OI) ₹147 Cr₹147 Cr
Other Income ₹2.18 Cr₹2.18 Cr
Interest ₹17 Cr₹17 Cr
Depreciation ₹17 Cr₹17 Cr
Profit Before Tax ₹116 Cr₹116 Cr
Profit After Tax ₹86 Cr₹86 Cr
Consolidated Net Profit ₹86 Cr₹86 Cr
Earnings Per Share (Rs)₹6.95₹8.59
PAT Margin (%)6.339.16
ROE(%)12.2916.17
ROCE(%)13.4815.59
Total Debt/Equity(x)0.520.60

Key Financials

Market Cap : ₹ 3,503.0 Cr
Revenue (TTM) : ₹ 840.7 Cr
Net Profit(TTM) : ₹ 61.9 Cr
EPS (TTM) : ₹ 6.2
P/E (TTM) : 56.6

Industry Peers & Returns1W1M1Y
GUFIC BIOSCIENCES -3.6% -5.5% -17.3%
SUN PHARMACEUTICAL INDUSTRIES 2.2% 2.1% -10.7%
DIVIS LABORATORIES 0.3% 6.4% 8.7%
CIPLA 6.8% 5.6% 5.2%
TORRENT PHARMACEUTICALS 1.6% -1.1% 5.1%
DR REDDYS LABORATORIES 4.6% -2.5% -4.3%
MANKIND PHARMA 0% -8.1% -8.5%
ZYDUS LIFESCIENCES 2.3% -3.6% -1.8%
LUPIN 0.1% -5.5% -10.7%


GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

0.00 %

5 Yr CAGR

0.00 %

Years Revenues % Change
Mar2025 ₹807 Cr
0.00
Mar2024 ₹807 Cr -


GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

0.00 %

5 Yr CAGR

0.00 %

Years Operating Profit % Change
Mar2025 ₹147 Cr
0.00
Mar2024 ₹147 Cr -

Operating Margins
Y-o-Y

0.00 %

5 Yr CAGR

0.00 %

Years Operating Margin% % Change
Mar2025 18.26%
0.00
Mar2024 18.26% -

GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

0.00 %

5 Yr CAGR

0.00 %

Years Profit After Tax % Change
Mar2025 ₹86 Cr
0.00
Mar2024 ₹86 Cr -

PAT Margins
Y-o-Y

-30.90 %

5 Yr CAGR

-30.90 %

Years PAT Margin(%) % Change
Mar2025 6.33 %
-30.90
Mar2024 9.16 % -

GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-19.09 %

5 Yr CAGR

-19.09 %

Years EPS % Change
Mar2025 ₹6.95
-19.09
Mar2024 ₹8.59 -

GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-13.53 %

5 Yr CAGR

-13.53 %

Years ROCE % Change
Mar2025 13.48%
-13.53
Mar2024 15.59% -

GUFIC BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹349.3
Current MarketCap: ₹ 3,503.0 Cr
Updated EOD on :Oct 21,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
GUFIC BIOSCIENCES

-3.6%

-5.5%

-17.3%

SENSEX

2.9%

1.7%

3.6%

GUFIC BIOSCIENCES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 2.3% 0.7% 1.7%
BSE SMALLCAP 2.3% -1.3% -6.2%
No NSE index found

You may also like the below Video Courses


FAQ about GUFIC BIOSCIENCES Financials


How the annual revenues of GUFIC BIOSCIENCES have changed ?

The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .

How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?

The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY .